FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080219 [Registered on: 10/02/2025] Trial Registered Prospectively
Last Modified On: 31/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Add on effects of Kharjuradi Modaka in the management of Pandu Roga with special reference to Iron Deficiency Anemia in children . 
Scientific Title of Study   Add on effects of Kharjuradi Modaka in the management of Pandu Roga with special reference to Iron Deficiency Anemia in children 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Praharsh Verma  
Designation  PG Scholar 
Affiliation  Banaras Hindu University  
Address  Department of kaumarbhritya balroga FoAy IMS BHU

Varanasi
UTTAR PRADESH
221005
India 
Phone  8224901666  
Fax    
Email  praharshvarma@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ravi shankar Khatri 
Designation  Assistant Professor  
Affiliation  Banaras Hindu University  
Address  Department of kaumarbhritya balroga FoAy IMS BHU

Varanasi
UTTAR PRADESH
221005
India 
Phone  9549182589  
Fax    
Email  drrskhatri@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ravi shankar Khatri 
Designation  Assistant Professor  
Affiliation  Banaras Hindu University  
Address  Department of kaumarbhritya balroga FoAy IMS BHU

Varanasi
UTTAR PRADESH
221005
India 
Phone  9549182589  
Fax    
Email  drrskhatri@gmail.com  
 
Source of Monetary or Material Support  
Sir Sunderlal Hospital,institute of medical sciences Banaras Hindu University  
 
Primary Sponsor  
Name  faculty of ayurveda ims banarass hindu university 
Address  Department of kaumarbhritya balroga faculty of ayurveda IMS Banaras hindu university 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Praharsh Verma   Sir Sunderlal Hospital  Sir Sunderlal hospital,25 no opd,department of kaumarbhritya balroga faculty of ayurveda ,ims, banaras hindu university,Varanasi
Varanasi
UTTAR PRADESH 
8224901666

praharshvarma@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethical committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:D509||Iron deficiency anemia, unspecified. Ayurveda Condition: PANDUROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Kharjuradi Modaka, Reference: NA, Route: Oral, Dosage Form: Modaka, Dose: 25(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Navayasa lohawith Kharjuradi Modaka , Reference: Charak chikitsa 16/70-71, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 100(mg), Frequency: od, Bhaishajya Kal: Pragbhakta, Duration: 2 Months, anupAna/sahapAna: No, Additional Information: -
3Comparator Arm (Non Ayurveda)DrugOther than Classical(1) Medicine Name: Ferrous ascorbate+folic acid with Kharjuradi Modaka , Reference: NA, Route: Oral, Dosage Form: Sharkara/ Syrup, Dose: 5(mg), Frequency: bd, Bhaishajya Kal: Madhyabhakta, Duration: 2 Months, anupAna/sahapAna: No, Additional Information: -
4Comparator Arm (Non Ayurveda)Drug-
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  14.00 Year(s)
Gender  Both 
Details  i.Patients diagnosed with Pandu (Iron Deficiency Anaemia).
ii.Patients of either sex of age group 5-14 years.
iii.Patients with Hb% within the range of 8 - 11gm/dl.
iv. Parents submitting written consent to participate in the study.  
 
ExclusionCriteria 
Details  i.Patients with anemia of origin other than Iron Deficiency.
ii. Patients who refuse for investigations, on follow-up were dropped from the study.
iii.Patients with Hb% less then 8gm/dl and more then 11gm/dl will not included in the study.
iv.Patients suffering with any serious infection.
Patients showing signs of intolerance to the drug or develop any other major disease requiring intensive treatment or stoppage of the treatment of anemia (trial or control) were dropped from study. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement in Hb%  significant changes in hb% over follow up at 30th day and 60th day of administering medicine  
 
Secondary Outcome  
Outcome  TimePoints 
1) Symptomatic relief
2) Improvement in Biochemical & hematological parameters 
significant changes in hb% over follow up at 30th day & 60th day of administering medicine  
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

OBJECTIVES –   

• To assess the additive effect of Kharjuradi Modaka in Pandu roga (Iron Deficiency Anemia).

• To Analyze study of Kharjuradi Modaka and its ingredients.

• To compare the additive effect of Kharjuradi Modak with Navayasa lauha & standard iron therapy in Pandu roga (Iron Deficiency Anemia).

Studying and recording the additive effect of Kharjuradi Modaka on biochemical parameter in Pandu Roga (Iron Deficiency Anemia).

 
Close